Background-Small stent area and residual inflow/outflow disease have been reported as the strongest intravascular ultrasound (IVUS) predictors of early stent thrombosis (ST) in patients with stable angina. IVUS predictors of early ST in patients with acute myocardial infarction have not been studied.
C oronary stent thrombosis (ST) occurs after implantation of either a bare metal stent 1 or a drug-eluting stent (DES). [2] [3] [4] The risk of early ST is similar between bare metal stents and DES, but very late ST occurs more frequently in patients receiving DES [5] [6] [7] because of its biological response. 8, 9 Regardless, the consequences of either acute, subacute, late, or very late ST are grave with a high rate of death, acute myocardial infarction (AMI), and repeat revascularization. 2, 4, 6 Clinical Perspective on p 247
Predictors of ST have been investigated predominantly in stable coronary disease. Especially, early ST (Յ30 days after procedure) has been associated with procedure-related factors as well as clinical factors related to thrombogenicity. 1, 5, 10 Intravascular ultrasound (IVUS) provides detailed qualitative and quantitative transmural coronary imaging. Small stent lumen area and residual inflow/outflow disease have been reported as the strongest IVUS predictors of ST in patients with stable angina. [11] [12] [13] [14] [15] However, IVUS findings associated with ST in AMI have not been studied previously despite the fact that acute coronary syndrome (especially AMI) is a known risk factor for ST because of elevated thrombogenicity and inflammation as well as procedural difficulties during primary percutaneous coronary intervention (PCI). 10, 16, 17 The aim of the present study was to evaluate postintervention IVUS findings of lesions that subsequently developed definite/probable early (within 30 days) ST in patients enrolled in the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) study.
Methods

Protocol Design and Randomization
The HORIZONS-AMI study was a prospective, open-label, multicenter, dual-arm, 2ϫ2 factorial, randomized trial in patients with ST-elevation-myocardial infarction presenting Յ12 hours after symptom onset, undergoing primary PCI. The 2 randomization arms consisted of (1) the direct thrombin inhibitor bivalirudin alone versus heparin plus a glycoprotein IIb/IIIa inhibitor (1:1 randomization) and (2) TAXUS EXPRESS paclitaxel-eluting stents versus otherwise equivalent EXPRESS bare metal stent (3:1 randomization). Details for the first randomization (pharmacology arm) and the second randomization have been reported. 18 
Quantitative and Qualitative Coronary Angiography
Coronary angiograms at baseline and immediately after PCI were performed in at least 2 orthogonal views after intracoronary nitroglycerin. Angiograms were analyzed at the Angiographic Core Laboratory of the Cardiovascular Research Foundation (New York, NY) using the CMS-GFT algorithm (MEDIS). Minimum lumen diameter (MLD) and average reference vessel diameter (RVD), obtained by averaging 5-mm segments proximal and distal to the target-lesion location, were used to calculate diameter stenosis (DS) [(1ϪMLD/RVD)ϫ100]. In-stent analysis was confined to the stent itself, and in-segment analysis included the stent plus 5-mm segments proximal and distal to the stent.
IVUS Substudy and Analysis
The IVUS substudy of HORIZONS was designed to compare poststent and 13-month follow-up images. As such, patients who had intercurrent adverse events were excluded from the primary analysis. 19 IVUS sites were preselected on the basis of the their desire to participate in this substudy and their agreement to perform index (poststent) and follow-up IVUS on consecutive patients in the angiographic follow-up cohort until at least up to 300 consecutive IVUS cases in whom neither stent thrombosis occurred nor bypass surgery was performed within 30 days were collected. Between March 25, 2005, and May 7, 2007, IVUS was completed in 406 patients, and the images were sent to the core laboratory. The current analysis included 12 patients (12 infarctrelated culprit lesions) with baseline IVUS images who had ST Ͻ30 days after enrollment and therefore were not included in the previous IVUS substudy report; they were compared with 389 patients (389 infarct-related culprit lesions) without early ST who were included in the previous IVUS substudy report after excluding 10 patients because of poor images and 7 patients because IVUS was not performed as the final step in the procedure (Figure 1 ).
Allowable IVUS systems included iLab, Galaxy, or ClearView (all with Atlantis SR Pro, 40-MHz catheters; Boston Scientific, Fremont, CA) or In Vision Gold with 20 MHz EagleEye catheters (Volcano Therapeutics, Rancho Cordova, CA). IVUS imaging was performed using motorized pullback at the speed of 0.5 mm/s to include the stent and Յ10-mm segments proximal and distal to the stent. Operators were allowed to react to the IVUS information; however, IVUS was then repeated as the last step of the procedure. IVUS studies were archived onto s-VHS tape, CD-ROM, or DVD and sent to an independent, treatment-allocationblinded, IVUS core laboratory (Cardiovascular Research Foundation) for quantitative and qualitative analyses using validated planimetry software (EchoPlaque, INDEC Systems, Inc, Mountain View, CA).
Quantitative analysis included measurement every 1 mm of the external elastic membrane, stent, and lumen cross-sectional areas (CSA) and volumes (for lesions in which motorized pullback was consistent and reliable) and plaque burden (plaqueϩmedia/external elastic membrane) within the stent and 10-mm-long segments proximal and distal to the stent. Proximal and distal reference segment measurements included the most normal-looking slice (maximum lumen with least plaque) and the most-diseased slice (smallest lumen and greatest plaque). Focal stent expansion was minimum stent CSA divided by mean reference lumen CSA, and diffuse stent expansion was mean stent CSA divided by mean reference lumen CSA. Stent symmetry was maximum divided by minimum stent diameter at minimum stent area site. Significant acute stent malapposition was defined as maximum malapposed area more than median. Significant intrastent tissue (plaque and/or thrombus) protrusion was defined as maximum protrusion area more than median that reduced the lumen to Ͻ4.0 mm 2 . Stent edge dissections were more than medial dissection with significant dissection defined as intralumen CSA Ͻ4 mm 2 or dissection angle Ն60°. Intralumen CSA did not include the lumen behind the dissection flap. Significant residual edge stenosis was a reference lumen CSA Ͻ4.0 mm 2 with Ն70% plaque burden Յ10 mm from each stent edge.
Statistical Analysis
Statistical analysis was performed using SAS software, Version 9.1 (SAS Institute Inc, Cary, NC). Continuous variables were displayed as median and quartiles [Q1, Q3] and compared using the MannWhitney U statistical test. Categorical variables were presented as frequencies and compared with 2 statistics or Fisher exact test (if there was an expected cell value Ͻ5). Probability values Ͻ0.05 were considered statistically significant and were not adjusted for multiple comparisons. Table 1 summarizes clinical, angiographic, and significant IVUS findings of patients with ST in this study. At a follow-up of 3 years, there were 12 cases of early (0 to 30 days) ST and 4 cases of late/very late (31 days to 3 years) ST in this cohort. Median time between index procedure and early ST was 5 (range, 0 to 29) days. Among these 12 patients, reinfarction occurred in 6 patients (50%: 5 Q-wave and 1 non-Q-wave myocardial infarction) and cardiac death in 4 patients (33.3%). There were 2 late STs (both at 201 days) and 2 very late STs (at 407 days and 972 days), all of whom presented with a Q-wave myocardial infarction and were treated with percutaneous revascularization.
Results
Clinical and Procedural Findings Comparing Early ST Versus No Early ST
Baseline demographics comparing 12 patients with definite/probable early ST to 389 patients without early ST are shown in Table 2 . Prerandomization heparin use was less frequent in early ST (41.7% versus 73.5%, Pϭ0.022). Eleven of 12 early ST patients received thienopyridine loading in the Emergency Department. One patient died in-hospital as the result of probable ST. The other 11 patients were discharged and had definite/probable early ST out-of-hospital. Among them, 1 patient stopped taking any thienopyridine in the hospital and had probable ST at day 24. The thienopyridine status of 2 probable ST patients was unknown at the time of the event. None of the other early ST patients discontinued thienopyridine before the ST event.
Angiographic findings and procedural characteristics are presented in Table 3 . Patients with definite/probable early ST had smaller baseline MLD and larger baseline %DS compared with patients without early ST; however, post-PCI MLD and %DS were not different between the 2 groups. Patients with early ST had a higher incidence of Thrombolysis In Myocardial Infarction (TIMI) grade 0/1 flow at baseline as well as final TIMI grade 0/1 flow after stenting.
IVUS Findings Comparing Early ST Versus No Early ST
Quantitative and qualitative IVUS findings comparing patients with versus without definite/probable early ST are shown in Tables 4 and 5 .
IVUS measurements at the most normal-looking reference segment slice were not different between the 2 groups. However, compared with patients without early ST, patients with early ST had smaller lumen and larger plaque burden at the most-diseased slice within 10 mm of the stent edge. Minimum lumen CSA Ͻ5 mm 2 , significant tissue protrusion, significant stent edge dissection, and significant residual edge stenosis were all more common in patients with early definite/probable ST; however, significant acute stent malapposition was similar in the 2 groups. Overall, 100% of patients with early ST had at least 1 abnormal feature compared with 22.9% of patients without early ST (PϽ0.001), and 50.0% of patients with early ST had Ն2 significant abnormal features compared with 2.6% of patients without early ST (PϽ0.001, Figure 2 ). Although the numbers were small, TIMI grade 0/1 flow was more common in patients with significant inflow/outflow disease in the overall cohort (Pϭ0.045). A representative case is shown in Figure 3 .
Discussion
The main findings of this IVUS substudy from the HORIZONS-AMI trial are the following: (1) The incidence of definite/ probable, clinically apparent early ST in this cohort was 3.0% (12/401 patients), similar to the overall HORIZONS study; (2) the minimum lumen CSA (because of tissue protrusion and/or stent underexpansion) was significantly smaller in patients with early ST; (3) minimum lumen CSA Ͻ5 mm 2 , significant tissue protrusion, significant edge dissection, and significant residual edge stenosis were more common in AMI patients with early ST; and (4) significant acute stent malapposition was not more common in early ST patients than in patients without early ST.
Minimum Lumen CSA, Stent Expansion, and Tissue Protrusion
There are 2 mechanisms of a small lumen after stenting: stent underexpansion and/or tissue protrusion through stent struts. Previous IVUS studies in patients with mostly stable angina have reported small stent CSA/stent underexpansion, stent edge dissection, and residual reference segment disease (but not tissue protrusion that is typically minimal) as the strongest IVUS predictors of ST. [11] [12] [13] [14] [15] In the current study, the minimum lumen CSA was significantly smaller in AMI patients with early ST either because of tissue (plaque and/or thrombus) protrusion or stent underexpansion or both. Culprit lesions in AMI are presumed to be thrombus-containing; tissue protrusion into the lumen through stent struts is more common and more significant than after stenting of stable lesions even after AMI lesions are treated with aggressive antithrombotic agents. 10, 16, 17, 20, 21 This does not suggest that stent expansion is unimportant in the AMI setting. Rather, it is the small lumen area-whether the result of stent underexpansion or tissue protrusion or the combination-that is the common denominator and a predictor of early ST. Thus, tissue protrusion must be factored into the assessment of the final result in AMI lesions; and significant stent underexpansion must still be avoided.
IVUS-documented tissue prolapse has been associated with a worse acute prognosis in the setting of PCI for AMI. 20 However, a previous IVUS report from HORIZONS-AMI showed that tissue protrusion disappeared at 13-month follow-up. 19 Therefore, tissue protrusion causing a small minimum lumen CSA would have its greatest effect early diminishing with time as it disappears during follow-up. In support of this, 3 of 4 significant tissue protrusions in patients with ST were not in the setting of significant stent underexpansion in the current study, and none of the patients with late or very late ST had tissue protrusion at baseline.
Although treatment with more aggressive antithrombotic agents has not reduced intrastent tissue protrusion in patients with AMI, tissue protrusion might be preventable by using prestent thrombectomy devices. The use of aspiration catheters was relatively low in this patient population. This is important because one predictor of early ST was minimal lumen CSA (caused by tissue protrusion), and the incidence of tissue protrusion was high. Thus, IVUS findings may be different after aggressive use of aspiration catheters. Of note, additional ballooning to treat tissue protrusion results in more myonecrosis presumably because of (1) additional stent expansion into the thrombus-laden plaque causing more tissue protrusion and/or (2) balloon-dilation associated distal embolization of the intrastent tissue. 20
Inflow/Outflow Disease
In this study, patients with definite/probable early ST had a smaller lumen and larger plaque burden at the most-diseased slice in the evaluated segment Յ10 mm from each stent edge along with a higher frequency of significant edge dissections (at least medial dissection narrowing the lumen or the inflow or outflow tract to Ͻ4 mm 2 ). 11, 12, 22 This was also seen in studies by Cheneau et al 12 and Fujii et al. 14 In the current study, TIMI grade 0/1 flow was associated with significant inflow/outflow disease on IVUS.
Stent Malapposition
Acute stent malapposition was not related to definite/probable early ST in the current study. This is compatible with previous reports after DES implantation 12, 14 indicating that the current trend to emphasize full apposition to avoid ST is misdirected. Conversely, Cook et al 23 reported that the presence and size of late stent malapposition were related to very late ST. In the current cohort, we only had 2 late ST and 2 very late ST-too few for meaningful analysis, although both late ST patients had a minimum stent area Ͻ5.0 mm 2 -and none of them had IVUS at the time of the late/very late ST event that would have been needed to document late acquired stent malapposition.
Clinical Implications
The pathogenesis of ST has not been fully understood. A combination of factors may be involved including procedurerelated factors, patient/lesion characteristics, antiplatelet therapy, stent thrombogenicity, and impaired endothelization. 1 Mechanical problems such as smaller lumen CSA within the stent (significant stent underexpansion and/or tissue protrusion) and residual disease outside of stent (residual stenosis and stent edge dissection) are more important in early ST, whereas biological problems such as stent malapposition or drug/polymer interaction with the vessel wall are more important in very late ST. Although few in number, the 2 patients with late ST (31 days to 1 year) had stent underexpansion, whereas the 2 patients with very late ST (beyond 1 year) had well-expanded stents at baseline.
Study Limitations
Not all patients of the HORIZONS-AMI trial were included in this IVUS substudy. We do not have data on platelet inhibition. The number of stent thromboses was very small. There was no correction for multiple comparisons, and the limited number of events gives very little power to detect significant relationships. Only 12 patients had early ST; when comparing data for 12 ST patients versus 389 control subjects, the variance of the difference between groups is large because of the smaller of those 2 sample sizes limiting the power of these findings. Similarly, multivariate or receiver operating characteristic analysis could not be performed because of the small number of early ST events, and the findings could not be normalized for vessel size. As a result, the current findings are considered exploratory in nature. Results with paclitaxeleluting stents and bare metal stents cannot be extrapolated (without reservation) to newer-generation DES. Analyses were unadjusted.
Conclusions
In the IVUS substudy from the HORIZONS-AMI trial, the 2 strongest predictors of definite/probable early ST were the minimum lumen CSA because of tissue protrusion after stenting) and inflow/outflow disease (residual stenosis or dissection) as well as a higher incidence of TIMI grade 0/1 flow at baseline and after stenting. 2 , significant tissue protrusion, significant stent edge dissection, and significant residual stenosis were all more common in patients with early ST than in patients without ST; however, significant acute stent malapposition was not different between 2 groups (A). Overall, 100% of patients with ST had at least 1 abnormal significant feature (minimum lumen CSA Ͻ5 mm 2 , tissue protrusion, stent edge dissection, and residual stenosis) compared with 23% in patients without ST, and 50% of patients with ST had Ն2 abnormal significant features compared with 3% in patients without ST (B). ST indicates stent thrombosis. A 41-year-old man who had hypercholesterolemia, smoking, and family history as cardiovascular risk factors presented with inferior ST-elevation-myocardial infarction. The initial angiogram showed a total occlusion at the proximal portion of right coronary artery. The cross-sectional slices (A through F) from the poststenting IVUS study are shown above the corresponding longitudinal reconstruction. Slices C and D show intrastent tissue (plaque/thrombus) protrusion compromising the lumen area, and slice F shows a residual stenosis distal to the stent. One day after stenting, the patient was readmitted to the hospital for ST that was treated with repeated coronary intervention. PCI indicates percutaneous coronary intervention.
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